Advertisement Pharma industry needs to transform investment and business strategies: Report - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Pharma industry needs to transform investment and business strategies: Report

KPMG, a network of firms providing audit, tax, and advisory services, has issued the Future Pharma report which emphasis that global pharmaceutical companies should transform in terms of investment and business strategies to gain back the trust of their stakeholders.

The report predicts the position of the pharmaceutical industry in 2020 and suggests strategies for achieving their goals.

The report found that industry returns on R&D investment reduced by half in 2010 compared to 1990.

Furthermore, the global shift in sales growth to the emerging markets indicates that a further squeeze is coming as margins in these markets are far tighter than in the West.

The report estimates that sales to emerging markets will triple from $154bn in 2010 to $487bn in 2020.